Elekta has released a new report outlining radiotherapy's utility in cancer care titled "2025 Impact Report, Precision Targeting, Global Impact: Cancer Radiotherapy in the 21st Century."
The report calls for broader adoption, proper reimbursement, and global access to advanced radiotherapy in cancer care. It draws on data and insights from clinical experts and patient experiences to show how radiotherapy improves outcomes for several cancers, including diseases of the brain, breast, gynecologic, head and neck, lung, pancreatic, prostate, and kidney.
The document also details radiotherapy’s role as a standalone treatment and in combination with other therapies, explains treatment options to patients, and features patient testimonials.
The full report is available at AboutAdaptive.com.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
